4//SEC Filing
GREAT POINT PARTNERS LLC 4
Accession 0000930413-09-000158
CIK 0001062216other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 5:01 PM ET
Size
17.2 KB
Accession
0000930413-09-000158
Insider Transaction Report
Form 4
GREAT POINT PARTNERS LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2009-01-05$0.61/sh−809,581$493,844→ 1,346,349 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−689,643$420,682→ 1,146,890 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−1,346,349$821,273→ 0 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−2,223,319$1,356,225→ 1,836,533 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−1,146,890$699,603→ 0 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−2,609,978$1,592,087→ 2,155,930 total(indirect: By Biomedical Value Fund, L.P.)
KROIN DAVID
10% Owner
Transactions
- Disposition from Tender
Common Stock
2009-01-05$0.61/sh−1,346,349$821,273→ 0 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−689,643$420,682→ 1,146,890 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−2,609,978$1,592,087→ 2,155,930 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−1,146,890$699,603→ 0 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−809,581$493,844→ 1,346,349 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−2,223,319$1,356,225→ 1,836,533 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
JAY JEFFREY R
10% Owner
Transactions
- Disposition from Tender
Common Stock
2009-01-05$0.61/sh−2,223,319$1,356,225→ 1,836,533 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−1,146,890$699,603→ 0 total(indirect: By Biomedical Offshore Value Fund, Ltd.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−2,609,978$1,592,087→ 2,155,930 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−1,346,349$821,273→ 0 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−809,581$493,844→ 1,346,349 total(indirect: By Biomedical Value Fund, L.P.) - Disposition from Tender
Common Stock
2009-01-05$0.61/sh−689,643$420,682→ 1,146,890 total(indirect: By Biomedical Offshore Value Fund, Ltd.)
Footnotes (2)
- [F1]Great Point Partners, LLC ("Great Point") is the investment manager of Biomedical Value Fund, L.P. ("BMVF") and by virtue of such status may be deemed to be the beneficial owner of the shares held by BMVF. Each of Dr. Jeffrey R. Jay, M.D. ("Dr. Jay"), as senior managing member of Great Point, and Mr. David Kroin ("Mr. Kroin"), as special managing member of Great Point, has voting and investment power with respect to the shares held by BMVF and may be deemed to be the beneficial owner of the shares held by BMVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares held by BMVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities.
- [F2]Great Point is the investment manager of Biomedical Offshore Value Fund, Ltd. ("BOVF") and by virtue of such status may be deemed to be the beneficial owner of the shares held by BOVF. Each of Dr. Jay, as senior managing member of Great Point, and Mr. Kroin, as special managing member of Great Point, has voting and investment power with respect to the shares held by BOVF and may be deemed to be the beneficial owner of the shares held by BOVF. Great Point, Dr. Jay and Mr. Kroin disclaim beneficial ownership of the shares held by BOVF, except to the extent of any pecuniary interest, and this report shall not be deemed to be an admission that they are the beneficial owners of such securities.
Documents
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001281446
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 5:01 PM ET
- Size
- 17.2 KB